A monoclonal IgG-1 was produced by culture of a murine hybridoma (3.8.6) by three different methods, namely culture in ascites, in serum-free media and in serum-supplemented media. IgG-1 was purified to homogeneity (as judged by SDS/PAGE under reducing conditions) from each medium by ion-exchange chromatography and h.p.l.c. Protein A chromatography. Oligosaccharides were released from each IgG-1 preparation by hydrazinolysis and radiolabelled by reduction with alkaline sodium borotritide, and 'profile' analysis of the radiolabelled oligosaccharide alditols was performed by a combination of paper electrophoresis and gel-filtration chromatography. This analysis indicated clear and reproducible differences in the glycosylation patterns of the three IgG-1 preparations. Sequential exoglycosidase analysis of individual oligosaccharides derived from each IgG-1 preparation was used to define these differences. Ascites-derived material differed from serum-free-culture-derived material only with respect to the content of sialic acid. IgG-1 derived from culture in serum-containing media had an intermediate sialic acid content and a lower incidence of outer-arm galactosylation than the other two preparations. These differences in glycosylation could not be induced in any IgG-1 preparation by incubating purified IgG-1 with ascites or culture medium. It is concluded that the glycosylation pattern of a secreted monoclonal IgG is dependent on the culture method employed to obtain it.
INTRODUCTION
All antibodies, whether monoclonal or serum-derived, are glycoproteins. In the case of IgG antibodies, glycosylation involves the attachment of N-glycans to the conserved Asn-297 residue in the Fc region of the heavy chains (for a review, see Rademacher et al., 1988) . Additional N-glycans may be attached to N-glycosylation sites (Asn-Xaa-Ser/Thr) in the hypervariable regions (Spiegelberg et al., 1970; Sox et al., 1970) . O-Glycans have not been reported on either human or murine IgG molecules.
Glycosylation of IgG influences both its biological function and its physicochemical properties (Winkelhake, 1978; Nose & Wigzell, 1983; Leatherbarrow et al., 1985; Malaise et al., 1987) . These include resistance to proteases, binding to monocyte Fc receptors, interaction with complement component CIq, feedback immunosuppression of IgG synthesis, and circulatory lifetime in vivo. Changes in the sequence of N-glycans attached to IgG have been clearly shown to be associated with disease activity in rheumatoid arthritis (Parekh et al., 1985) . It has further been suggested that such changes contribute to the pathology of the disease by predisposing the IgG to self-associate into immune complexes, and by activating macrophages by binding to the GlcNAc receptor on the surface of these cells (Rademacher et al., 1988) .
Monoclonal antibodies are finding increasing use as specific in vitro and in vivo diagnostic reagents, as therapeutic agents, and as ligands for affinity purification of both macromolecules and smaller-molecular-mass substances. Murine monoclonal antibodies are generally obtained in one of three ways, namely after cell culture in ascites, serum-containing media or serum-free media. It can be the case that production methods for a given antibody can vary through a process development program, usually involving initial isolation from ascites to large-scale production from a variety of in vitro culture techniques. Given the importance of glycosylation to the functional properties of IgG, and the preference to obtain a structurally defined, or at least biochemically consistent, product for in vivo administration, we have compared the glycosylation of a murine IgG monoclonal antibody derived after expression in ascites, serum-containing media and serum-free media. In each case, the IgG was purified from each culture fluid using the same protocol. The results clearly indicate that IgG glycosylation is significantly influenced by culture method.
from Oxford GlycoSystems (Abingdon, Oxon, U,K.). Dowex AGSOX 12 (HI) and Chelex 100 (Na+) were from Bio-Rad (Watford, Herts., U.K.).
Ascites culture
The origin of the hybridoma used in this study is as follows. Mice (Balb/c) were injected intraperitoneally on day 0 with a mixture (1:1, v/v) of protein antigen (U.S. patent No 4; 631509113082) (50 mg ml-') in Tris-buffered saline (TBS)/ complete Freund's adjuvant. On day 14 and then on day 38, the mice were injected with a mixture (1: 1, v/v) of protein antigen (50 mg ml-') in TBS/incomplete Freund's adjuvant. On day 42, spleens were surgically removed and cells fused with the myeloma partner to form hybridomas as described by Brown et al. (1980) . Positive hybridoma clones were identified using a radioimmunoassay, and positive clones were sub-cloned at least twice. After karyotypic analysis, stable sub-clones were then injected into the intraperitoneal cavities of Balb/c mice which had been pretreated intraperitoneally with 0.5 ml of Pristane 5 days prior to injection of hybridoma cells. Hybridoma cells were injected (5 x 106 cells/mouse) in 0.5 ml of Dulbecco's modified Eagle's medium (without foetal bovine serum). Ascites fluid was collected (in heparin), and pooled from several mice for subsequent isolation of the monoclonal IgG. The same hybridoma was used to derive the ascitic IgG as was used to derive IgG from cell culture. Serum culture Murine hybridomas were inoculated into a 3 litre spinner at a seeding density of around 2 x 105 cells/ml and were harvested following 3.5 days of growth at 1 x 106 cells/ml. The medium contained 2% foetal calf serum, 2,ug of insulin/ml, 10,ug of bovine transferrin/ml and Iscove's basal medium. Cell viability was measured by Trypan Blue staining and phase-contrast light microscopy using a described procedure (Adams, 1990) . Cells were harvested at a viability of > 95 %. In addition to microscopic examination, assay of the cell-free supernatant for lactate dehydrogenase activity also indicated negligible cell lysis.
Serum-free culture
The conditions were essentially the same as described above, except that 0.1 % BSA was used in place of 2 % foetal calf serum.
Cells were harvested at a viability of > 95 %, as described above.
Recovery of IgG-containing culture medium Culture fluids were initially filtered to remove cells and debris using a 0.2,um-pore-size Sartobran capsule filter. The clarified fluid was then concentrated approx. 15-fold using a miniUltrasort with a 20 kDa molecular mass cut-off. Purification of IgG IgG was purified from each culture medium using the following protocol. Concentrated medium was diluted 10-fold (with 10 mMsodium acetate, pH 5.9) and loaded on to an S-Sepharose column (dimensions 6 cm x 30 cm; pre-equilibrated with 20 mM-sodium acetate, pH 5.9, containing 10 mM-NaCI). IgG was then eluted (20 mM-dibasic sodium phosphate, pH 5.9, containing 85 mmNaCI); the pH of the eluate was adjusted to 6.9, and then the eluate was loaded on to a Q-Sepharose column (3 cm x 30 cm; pre-equilibrated in 20 mM-sodium phosphate, pH 5.9, containing 85 mM-NaCI). The IgG was not bound to Q-Sepharose under these conditions, whereas most contaminating proteins were. The unbound IgG fraction so obtained was diluted 3-fold (with 20 mM-sodium acetate, pH 5.5) and loaded on to the S-Sepharose column (equilibrated with 20 mM-sodium acetate, pH 5.5, containing 30 mM-NaCl). The IgG bound to the S-Sepharose, and after washing (5 column vol. of equilibration buffer) it was eluted (with 20 mM-sodium acetate, pH 5.5, containing 200 mM-NaCl). After this initial purification, samples were ultra-purified by h.p.l.c. Protein A chromatography. The IgG sample was dialysed into sodium phosphate buffer, pH 8.9, containing 3 M-NaCl and 1.5 M-glycine, an aliquot was loaded on to an Affi-Prep Protein. A cartridge, and the IgG was eluted using a pH 4.0 solution of 0.1 M-citric acid. The final ultra-purified IgG preparation was shown to be pure and homogeneous by SDS/PAGE analysis (according to Laemmli, 1970) under reducing conditions (see Fig. 1 ).
Tryptic mapping of monoclonal IgG-l preparations To IgG samples at I mg/ml in phosphate-buffered saline (PBS) was added guanidine hydrochloride (final concentration of 6 M), followed by 10,1 of 500 mM-dithiothreitol (DTT). Samples were incubated (30 min) under nitrogen at 37 'C. The resultant reduced protein was carboxymethylated by addition of a volume (100 ,ul) of 500 mM-iodoacetate in 100 mM-Tris/HCI (pH 8.15)/6 Mguanidine HCI/2 mM-EDTA to each sample tube, followed by a 1 h incubation at 37 'C in the dark under nitrogen. The samples were then dialysed overnight against PBS. Reduced/ carboxymethylated samples (500 ,ug) were digested overnight at 37 'C with 10 ,1 of trypsin at 1 mg/ml. Each sample was brought to 0. Release, labelling and isolation of IgG-associated glycans Three separate aliquots (approx. 1 mg) of each purified IgG preparation were exhaustively dialysed (micro-flow dialysis) against 0.1 % (v/v) TFA. The dialysed solution was lyophilized and then cryogenically dried over activated charcoal at -196 'C (< 1011 Pa). The dried preparation was then incubated with anhydrous hydrazine, and the liberated N-glycans were re-Nacetylated, separated from peptide, radiolabelled and purified as follows. The samples were suspended in 200 ,u1 of freshly distilled anhydrous hydrazine (toluene/CaO; 25 'C; 1.33 kPa) under an argon atmosphere. The temperature was raised at 17°C/h from 30 to 85 'C, and then maintained at 85 'C for a further 12 h. The hydrazine was removed by evaporation under reduced pressure (< 10 Pa) at 25°C followed by repeated (5 x ) flash evaporation from anhydrous toluene. The hydrazinolysates were N-acetylated by the addition of excess (5 x over amino groups) acetic anhydride (0.5 M) in saturated NaHCO3 at 4°C for 10 min. The temperature was then raised to 25°C, a second aliquot of acetic anhydride added and the reaction. allowed to proceed for a further 50 min. Following N-acetylation, the samples were applied to a column of Dowex AG5OX 12 (H+), eluted with water and evaporated to dryness (27°C). The desalted samples were dissolved in water and applied to Whatman 3MM chromatography paper. Descending paper chromatography (27°C, 60 % relative humidity) was subsequently performed with butan-lol/ethanol/water (4: 1: 1, by vol.) (solvent I). After 48 h, the first 5 cm measured from the origin was eluted with water, flashevaporated to dryness (27°C), redissolved in a 5 x molar excess of 1 mM-copper(II) acetate, and incubated at room temperature for 45 min. After passage through a tandem column of Chelex 100 (Na+)/Dowex AG50X 12 (H+), the oligosaccharides were flash-evaporated to dryness (27°C) and reduced with a 5 x molar excess of 6 mM-NaB3H4 (12 Ci/mmol; Amersham) in 50 mM-NaOH adjusted to pH 11 with saturated boric acid (30°C, 4 h). The mixture was then acidified (pH 4-5) with I M-acetic acid and applied to a column of Dowex AGSOX 12 (HI), eluted with water, evaporated to dryness (27°C) and flash-evaporated (27°C) from methanol (5 x ). The samples were then applied to Whatman 3MM chromatography paper and subjected to descending paper chromatography for 2 days using solvent I.
Radiochromatogram scanning was performed with an LB230 Berthold radiochromatogram scanner. The radioactivity remaining at the origin was subsequently eluted with water. The isolated oligosaccharides were subjected to high-voltage paper electrophoresis in pyridine/acetic acid/water (3:1:387, by vol.; pH 5.4, Whatman 3MM, 80 V/cm) in order to determine the relative proportions of neutral and acidic components. Samples of the reduced (3H-labelled) oligosaccharides were also subjected to exhaustive neuraminidase digestion, and the products were separated by high-voltage paper electrophoresis. All radioactivity remaining at the origin following neuraminidase digestion was recovered by elution with water and desalted by using a tandem column of Chelex 100 (Na+)/Dowex AGSOX 12 (H+)/AG3X 4A (OH-)/QAE-Sephadex A-25. The eluate and washings were evaporated to dryness, resuspended in 175 1l of a 2 mg/ml partial dextran hydrolysate, and applied to a Bio-Gel P4 (-400 mesh) gel-permeation chromatography column (1.5 cm x 200 cm). The eluant was monitored for radioactivity by using an LB503 Berthold h.p. Monosaccharide composition analysis This was performed essentially as described by Chaplin (1982) . To the salt-free cryogenically dried hydrazinolysate (after re-Nacetylation) from 0.2 mg of salt-free cryogenically dried IgG preparation containing 10 nmol of scyllo-inositol was added 0.2 ml of anhydrous methanolic HCI (0.5 M). The mixture was incubated under anhydrous conditions at 85 'C for 16 h, after which pyridine (10 ,ul) and acetic anhydride (5 ,u) were added. The reaction mixture was vortex-mixed and left at room temperature for 1 h. Reagents were removed by rotary evaporation, traces of pyridine were removed by repeated (3 x ) flash evaporation from methanol (100 ,u), and the rotary-evaporated mixture was then again cryogenically dried prior to silylation. Silylation of the 1-0-methyl glycosides was performed by the addition of 25 ,1 of Sil-A (Sigma), brief sonication of the mixture and incubation at room temperature for 30 min. The excess Sil-A was removed by rotary evaporation, and the 1-0-methyl trimethylsilyl glycosides were taken up in anhydrous n-hexane. The 1-0-methyl TMS glycosides were separated by capillary GC (using a Hewlett-Packard 5890 Series II gas chromatograph), identified with respect to retention time and mass spectrum by reference to standard compounds, and quantified from the flame ionization detector response relative to scyllo-inositol.
RESULTS

Purity of IgG antibody
Each final antibody preparation was deemed to be > 98 % pure, as judged by SDS/PAGE analysis (Fig. 1) Table 1 are consistent with the presence of only complex bi-antennary N-glycans on each IgG preparation. This is expected from previous reports on the analysis of murine IgG (Mizuochi et al., 1987) . The data further suggest that a similar number of Nglycan chains are present on each IgG preparation, as judged by the similar amounts of mannose and N-acetylglucosamine. The gel-filtration chromatograms (see later) showed that the glycans in all three preparations all contained the conserved trimannosyl chitobiosyl core. Assuming a content, therefore, ofthree mannose residues per glycan chain, and a molecular mass of 150 kDa for the IgG, the number of glycan chains can be calculated (see Table  1 ). These calculations indicate that, besides the presence of two chains in the Fc region, additional glycosylation occurs in the Fab region. This is supported by the detection of di-sialylated oligosaccharides in two of the IgG preparations. There are, however, clear differences with respect to the terminal processing of these chains, i.e. concerning the addition of outer-arm galactose and sialic acid residues.
Relative molar content of neutral, mono-and di-sialylated oligosaccharide chains in each IgG preparation A sample of the total radiolabelled alditol pool from each IgG preparation was fractionated on the basis of charge by paper electrophoresis before and after treatment with neuraminidase. The resulting radioelectrophoretograms for the untreated alditols are shown in Fig. 2 (the triplicate analyses generated indistinguishable chromatograms for each preparation). By recovery of radioactivity from paper the relative contents of neutral, mono-sialylated and di-sialylated oligosaccharides in the three preparations could be determined (Table 2 ). These data are again as expected from previously reported analyses of murine IgG, and are consistent with the sialic acid composition data presented in Table 1 . The radioelectrophoretogram after treatment with neuraminidase showed only a single peak at the origin (results not shown), indicating essentially quantitative de-sialylation. These data show that the three preparations differ with respect to their content of sialylated oligosaccharides. The ascites-derived material had no detectable sialylated oligosaccharides, the IgG derived after culture in serum-free media had a significant content of sialylated oligosaccharides, and the IgG derived after culture in serum-containing media had an intermediate content. The presence of di-sialylated oligosaccharides suggests the occurrence of Fab glycosylation (Rademacher et al., 1986) . Di-sialylated oligosaccharides are reported to be absent from Fc, based on both structural considerations and experimental analysis. The IgG must therefore carry an N-glycosylation site in the Fab region. Assuming the IgG preparation to be truly clonal with respect to amino acid sequence, each IgG would be expected to carry at least four N-glycan chains (two in the Fc and two in the Fab). The calculations shown in Table 1 indicate that each IgG carries only 0.3-0.4 chains in the Fab region. Attachment of Nglycans to the N-glycosylation sites in the Fab is therefore incomplete, as observed previously for another murine monoclonal antibody (Arvieux et al., 1986) .
Gel-filtration chromatograms of the deacidified oligosaccharides recovered from each IgG preparation
The oligosaccharide alditol pool after neuraminidase treatment was fractionated by Bio-Gel P4 (-400 mesh) gel-permeation chromatography. The resulting chromatograms are shown in Fig. 3 . Individual fractions were pooled as indicated, and the relative radioactivity in each was determined (Table 3 ). These chromatograms indicate that the three IgG preparations differ not only with respect to sialylation but also with respect to other structural determinants. To define these differences further, fractions A, B, C and D from each IgG preparation were analysed by sequential exoglycosidase digestion (Kobata, 1984) . the position of glycosyl linkages, is based on a consideration of the specificities of the glycosidases used and the change in hydrodynamic volume induced by each one (Kobata et al., 1987) . In the case of the core region, the position of glycosyl linkages is presumed to be consistent with the known biosynthetic pathway for N-glycans (Kornfeld & Kornfeld, 1985) . The sequences of oligosaccharides in each of fractions A, B, C and D are shown in Fig. 4 (Tables I and 2 and Fig. 2 ), but not with respect to the sequece and reIative incidence of the neutral portion of their attached oligosaccharides (Table 3 and Fig. 3 ).
MatenA derived from culture inserum-cntaig media had an intermediate siaic acid content (Tables I and 2 (Fig. 1) ,, and all three IgG preparations were indistinguishable by tryptic mapping and amino acid composition analysis. Numerous factors have now been reported to influence glycosylation (Yet et al., 1988) . Traditionally, most emphasis has been on the effect of polypeptide structure (Sheares & Robbins, 1986) and cell type (Parekh et al., 1987) on the glycosylation of the secreted polypeptide. It is, however, becoming increasingly clear that environmental factors can also profoundly influence glycosylation (for a review, see Goochee & Monica, 1990) . These include the effects of hormones (Goochee & Monica, 1990) , culture method (Anderson et a., 1985) , age of cell culture (Curling et al., 1990) , pH (Matlin et al., 1988) , buffers (Oda et al., 1988) , and the content of added serum during culture in serumcontaining media (Megaw & Johnson, 1979) . For example, Anderson et al. (1985) observed major differences in the glycosylation of a monoclonal IgM derived after culture in ascites and after cell culture in vitro. Megaw & Johnson (1979) found major differences in the glycosylation ofthe major secreted glycoprotein after culture of a murine parietal yolk sac carcinoma in media containing different levels of foetal calf serum, but there were no detectable changes in the amino acid composition of this glycoprotein. While in no case are the details of the molecular mechanisms by which such extracellular factors influence the intracellular glycosylation process understood, the results presented here lend support to the view that production method has an influence on the glycosylation of a secreted monoclonal antibody. To establish the generality or otherwise of this observation, however, will require similar analysis of other monoclonal antibodies. In this regard, one similar study has been Glycosylation differences in a murine monoclonal antibody recently reported (Moellering et al., 1990) which suggested that glycosylation of a muuine IgG-I monoclonal antibody was nt influenced by production method. In this latter study, peptide Nglycosidase F (PNGase F) was used to liberate oligosaccharides from native, undenatured IgG. Given the current knowledge on the activity of this enzyme (Nuck et al., 1990 ) and the relative inaccessibility of Fc N-glycans in native lgG (Sutton & Phillips, 1982) , it is hkkely that PNGase F released only a small, posibly Fab-associated, population (Hymes & Mullinax, 1979; Malaise et at, 1987; Middagh & Litman., 1987) .
